Glaukos (GKOS) director awarded 623 restricted stock units

Rhea-AI Filing Summary

Glaukos Corporation director Denice Torres reported receiving a new equity grant. On January 2, 2026, she was awarded 623 shares of Glaukos common stock at a price of $0 per share, reflecting a grant of restricted stock units under the company’s Director Compensation Policy. These units will vest in full on the one-year anniversary of the grant date and will be settled in the same number of common shares.

After this grant, Torres beneficially owns 22,334 shares of Glaukos common stock, including 2,731 restricted stock units that have not yet vested or been delivered. The filing classifies her holdings as directly owned and confirms her role as a director, with no indication that she is a 10% owner or an officer of the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Torres Denice

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	623	$0.00	--

Holdings After Transaction: Common Stock — 22,334 shares (Direct)

Footnotes (1)

1. Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. Includes2,731 restricted stock units that have not yet vested or been delivered to the Reporting Person.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Torres Denice

(Last) (First) (Middle)

C/O GLAUKOS CORPORATION

ONE GLAUKOS WAY

(Street)

ALISO VIEJO CA 92656

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A		623(1)	A	$0	22,334(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock.

2. Includes2,731 restricted stock units that have not yet vested or been delivered to the Reporting Person.

	Diana Scherer, Attorney-in-Fact	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Glaukos (GKOS) director Denice Torres report in this Form 4 filing?

Denice Torres reported receiving a grant of 623 shares of Glaukos common stock, in the form of restricted stock units, on January 2, 2026, at a price of $0 per share.

How many Glaukos (GKOS) shares does Denice Torres beneficially own after this transaction?

Following the reported grant, Denice Torres beneficially owns 22,334 shares of Glaukos common stock, including 2,731 restricted stock units that have not yet vested or been delivered.

What are the vesting terms of the restricted stock units granted to Denice Torres by Glaukos?

The filing states that the restricted stock units will vest in full on the one-year anniversary of the grant date and will be payable in an equivalent number of shares of Glaukos common stock.

Why did Glaukos grant restricted stock units to Denice Torres?

The 623 restricted stock units were granted to Denice Torres pursuant to Glaukos’ Director Compensation Policy, which provides equity awards as part of compensation for board service.

Is Denice Torres a director, officer, or major shareholder of Glaukos (GKOS)?

The filing identifies Denice Torres as a director of Glaukos Corporation. She is not listed as an officer or a 10% owner in this report.

Are the shares in this Glaukos Form 4 transaction held directly or indirectly by Denice Torres?

The Form 4 indicates that the 22,334 shares of Glaukos common stock reported after the transaction are held with direct ownership by Denice Torres.